Medicare Part B Demo Coverage Should Be Broad, Senate Staffer Tells CMS
Executive Summary
Senate drafters of the Medicare Rx law intended the Part B "replacement" drug demonstration project to include oral drugs that do not replace an injectable product, a staffer for Sen. Olympia Snowe (R-Maine) told the Centers for Medicare & Medicaid Services
You may also be interested in...
Medicare Part B Oral Chemotherapy Demo Limited To Approved Indications
Reimbursement for oral chemotherapy products under a Medicare Part B demonstration project will be limited to FDA-approved indications, the Centers for Medicare & Medicaid Services' proposed criteria say
Medicare Part B Demonstration Project Will Be Set In “Weeks” – CMS
The Centers for Medicare & Medicaid Services is "weeks" away from unveiling a $500 mil. demonstration project on coverage of alternatives to drugs reimbursed under Medicare Part B
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011